Implemented myeloma management with whole-body low-dose CT scan: a real life experience

Silvia Mangiacavalli, Sara Pezzatti, Fausto Rossini, Elisa Doni, Federica Cocito, Silvia Bolis, Alessandro Corso

Research output: Contribution to journalArticle


A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60% had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29% of patients. Patients presenting with extramedullary masses were 10%. Radiological progression was documented in 9% of the population with available follow-up. Additional pathological incidental findings were detected in 28 patients (14.5%), most located in the chest region (68%). In conclusion, our real-life data shows that WBLDCT scan represents a reliable imaging tool for decision-making process for multiple myeloma management in different disease phases, providing significant additional information on the presence of soft tissues plasmacytomas detection as well as the presence of pathological incidental findings.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalLeukemia and Lymphoma
Publication statusAccepted/In press - Jan 20 2016



  • Bone disease
  • multiple myeloma
  • whole body low-dose computed tomography

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this